MedPath

Psychological treatment of anxiety and depression in patients with Parkinson's disease: A pilot program

Completed
Conditions
Parkinson's disease
Anxiety
Depression
Mental Health - Anxiety
Mental Health - Depression
Neurological - Parkinson's disease
Registration Number
ACTRN12616000785404
Lead Sponsor
Macquarie University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
40
Inclusion Criteria

Patients with Parkinson's disease and their primary carer will be recruited. Eligibility criteria will include aged 50 years or over, the presence of patient reported clinically significant anxiety symptoms (Geriatric Anxiety Inventory > 6) and depressive symptoms (Geriatric Depression Scale -15 scores > 5). Use of psychiatric medication will be required to be stabilised one month prior to study entry. Other than being the carer or spouse of the participant with Parkinson’s disease, and being over the age of 18 years, no other inclusion criteria are required.

Exclusion Criteria

Exclusion criteria will be the presence of active suicide ideation, psychos is, substance abuse, uncontrolled bipolar disorder or significant cognitive impairment (2 or more errors on the Six Item Screener for Cognitive Impairment). Participants or carers with insufficient English Language skills (unable to read a newspaper) will also be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in patient anxiety as assessed by the Geriatric Anxiety Inventory[Baseline and 10 weeks post commencement of the intervention (Post Intervention)];Change in patient depression assessed by the Geriatric Depression Scale (15 item)[Baseline and 10 weeks post commencement of the intervention (Post Intervention)];Change in patient quality of life as assessed by the World Health Organisation Quality of Life scale (short form) - WHOQOL-BRE[Baseline and 10 weeks post commencement of the intervention (Post Intervention)]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath